Hemo Organic Ltd.

8.05 ▼0%

19 February 2024, 04:01:00 PM

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.hemoorganicltd.com
Market Cap 2.79 Cr.
Enterprise Value(EV) 2.77 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.25 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.89 Trailing Twelve Months Ending 2023-12
Book Value / Share -0.24 Trailing Twelve Months Ending 2023-12
Price to Book Value -33.11 Calculated using Price: 8.05
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.35 Cr. 3,465,900 Shares
FaceValue 10
About Hemo Organic Ltd.
Dinesh Allorga incorporated as public limited Company in August 1992. It is engaged in production and sale of ayurvedic medicines and chemicals.

Hemo Organic Ltd. Delivery

Delivered Qty
Traded Qty

Hemo Organic Ltd. Performance

1 Day
1 Week
+4.95%
1 Month
+13.06%
3 Month
+11.19%
6 Month
+30.89%
1 Year
-13.16%
2 Year
-63.16%
5 Year
-50.31%
10 Year
-32.12%

Hemo Organic Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -7.77 -99.33 -19.17 -44.9 -61.38 -17.52 -53.35 -180.16 0
Return on Capital Employed (%) -7.51 -96.61 -19.17 -39.88 -43.09 -11.35 -44.09 -89.29 -486.91
Return on Assets (%) -7.67 -101.27 -11.32 -15.99 -14.38 -4.75 -47.99 -65.16 -36.17

Hemo Organic Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1 0 0 0 0 0 0 0 0
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Curr. Liab. 0 0 1 1 1 0 0 0 0 0
Minority Int.
Equity & Liab. 1 0 1 1 1 0 0 0 0 0
Non Curr. Assets 1 0 0 0
Curr. Assets 0 0 1 1 1 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 1 0 1 1 1 0 0 0 0 0

Hemo Organic Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 0 0 1 0 0 0 0 0
Other Income 0
Total Income 0 0 1 0 0 0 0 0
Total Expenditure 0 0 -1 0 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0 0 0 0
Interest
Depreciation 0 0
Taxation
Exceptional Items -1
PAT 0 -1 0 0 0 0 0 0 0 0
Adjusted EPS 0 -2 0 0 0 0 0 0 0 0

Hemo Organic Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -1 0 0 0 0 0 0
Cash Fr. Inv. 0 1 0 0 0
Cash Fr. Finan. 0 0 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Hemo Organic Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 16.85 16.85 16.85 16.85 16.85 16.85 16.85 16.85 16.85
Public 83.15 83.15 83.15 83.15 83.15 83.15 83.15 83.15 83.15
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Hemo Organic Ltd. Announcements

Mon, 12 Feb 2024
Quarterly Results For Quarter Ended On December 31 2023
Quarterly Results for Quarter ended on December 31 2023
Mon, 12 Feb 2024
Board Meeting Outcome for Board Meeting Outcome
Board Meeting Outcome
Tue, 06 Feb 2024
Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On Monday February 12 2024.
Hemo Organic Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve and take on record the unaudited Standalone Financial Results of the Company for the quarter ended on December 31 2023 as per Regulation 33 of the Listing Regulation and Any other item of business as may be decided by the board of directors of the company. In this connection and in continuation of our intimation regarding Closure of Trading Window for the Insiders of the Company vide letter dated December 30 2023 the trading window for dealing in the securities of the Company is already closed for the Insiders of the Company from Monday January 01 2024 till 48 hours declaration and publication of Unaudited Standalone Financial Results for the quarter ended December 31 2023.

Hemo Organic Ltd. Technical Scans

Mon, 19 Feb 2024
Close Crossing Last Week High Close Crossing Last Week High
Close Crossing Last Month High Close Crossing Last Month High
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
Closing Above Previous High For 3 Days Closing Above Previous High For 3 Days

Hemo Organic Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 373,756.40 1,553.75 +0.7%
Cipla Ltd. 117,370.75 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. 106,155.83 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. 97,309.86 6,766.05 +0.1%
Divi's Laboratories Ltd. 96,809.75 3,642.80 -0.2%
Zydus Lifesciences Ltd. 91,584.23 904.80 +1.3%
Torrent Pharmaceuticals Ltd. 88,295.34 2,611.70 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.97 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-12 31.65 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.30 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.28 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-12 70.00 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 30.80 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.10 2,611.70 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.99 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-12 4.53 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.95 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-12 7.43 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.71 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.35 2,611.70 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,611.70 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,611.70 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,611.70 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,611.70 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,553.75 +0.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,453.75 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,344.05 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,766.05 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,642.80 -0.2%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 904.80 +1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,611.70 +0.4%

Hemo Organic Ltd. FAQ's

What is Hemo Organic share price?

Can I buy Hemo Organic shares now?

What is the Market Cap of Hemo Organic?

What is the 52 Week High and Low of Hemo Organic?